![Pharmacy | Free Full-Text | Treatment Strategy for Dyslipidemia in Cardiovascular Disease Prevention: Focus on Old and New Drugs | HTML Pharmacy | Free Full-Text | Treatment Strategy for Dyslipidemia in Cardiovascular Disease Prevention: Focus on Old and New Drugs | HTML](https://www.mdpi.com/pharmacy/pharmacy-06-00010/article_deploy/html/images/pharmacy-06-00010-g001.png)
Pharmacy | Free Full-Text | Treatment Strategy for Dyslipidemia in Cardiovascular Disease Prevention: Focus on Old and New Drugs | HTML
![Pemafibrate, a New Selective PPARα Modulator: Drug Concept and Its Clinical Applications for Dyslipidemia and Metabolic Diseases | SpringerLink Pemafibrate, a New Selective PPARα Modulator: Drug Concept and Its Clinical Applications for Dyslipidemia and Metabolic Diseases | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs11883-020-0823-5/MediaObjects/11883_2020_823_Fig2_HTML.png)
Pemafibrate, a New Selective PPARα Modulator: Drug Concept and Its Clinical Applications for Dyslipidemia and Metabolic Diseases | SpringerLink
![Myopathy with statin–fibrate combination therapy: clinical considerations | Nature Reviews Endocrinology Myopathy with statin–fibrate combination therapy: clinical considerations | Nature Reviews Endocrinology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnrendo.2009.151/MediaObjects/41574_2009_Article_BFnrendo2009151_Fig1_HTML.jpg)
Myopathy with statin–fibrate combination therapy: clinical considerations | Nature Reviews Endocrinology
MedSeptic - Fibrate:- In pharmacology, the fibrates are a class of amphipathic carboxylic acids. They are used for a range of metabolic disorders, mainly hypercholesterolemia (high cholesterol), and are therefore hypolipidemic agents. . . . . #
![Is There a Role for Fibrates in the Management of Dyslipidemia in the Metabolic Syndrome? | Arteriosclerosis, Thrombosis, and Vascular Biology Is There a Role for Fibrates in the Management of Dyslipidemia in the Metabolic Syndrome? | Arteriosclerosis, Thrombosis, and Vascular Biology](https://www.ahajournals.org/cms/asset/40361ba0-d5ba-4974-81ab-f1cb6fd8dce5/9ff3.jpeg)
Is There a Role for Fibrates in the Management of Dyslipidemia in the Metabolic Syndrome? | Arteriosclerosis, Thrombosis, and Vascular Biology
![Proposed dual mechanism for fibrate mediated repression of PCSK9 to... | Download Scientific Diagram Proposed dual mechanism for fibrate mediated repression of PCSK9 to... | Download Scientific Diagram](https://www.researchgate.net/publication/223809819/figure/fig4/AS:270248867790876@1441443759632/Proposed-dual-mechanism-for-fibrate-mediated-repression-of-PCSK9-to-increase-LDL.png)